![Shu Kam Mok](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shu Kam Mok
Direttore/Membro del Consiglio presso
ASTRAZENECA PLC
Patrimonio netto: 974 547 $ in data 30/06/2026
Profilo
Shu Kam Mok was the founder of Sanomics Ltd. founded in 2015, holding the title of Chairman.
Dr. Mok is also the founder of Chinese Thoracic Oncology Group,Asia Thoracic Oncology Research Group,Aurora Tele-Oncology Ltd...
Dr. Mok currently serves as Independent Non-Executive Director at AstraZeneca PLC since 2019, Non-Executive Independent Director at Lunit Usa, Inc., Director at Insighta Ltd., and Secretary at the Chinese Society of Clinical Oncology.
Former positions include Chairman-Clinical Oncology Department at The Chinese University of Hong Kong, Chairman at ACT Genomics Co. Ltd., Lead Independent Non-Executive Director at HUTCHMED (China) Ltd. from 2025 to 2026, Director at American Society of Clinical Oncology, Inc., and Treasurer at the International Association for the Study of Lung Cancer.
Education includes undergraduate and doctorate degrees from the University of Alberta.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 3.500 ( 0% ) | 654 998 $ | 30/06/2026 | |
| 12/05/2026 | 136.705 ( 0,02% ) | 319 549 $ | 31/05/2026 |
Posizioni attive di Shu Kam Mok
| Società | Posizione | Inizio |
|---|---|---|
| ASTRAZENECA PLC | Direttore/Membro del Consiglio | 01/01/2019 |
Chinese Society of Clinical Oncology | Segretario Aziendale | - |
Lunit Usa, Inc. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Shu Kam Mok
| Società | Posizione | Fine |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Direttore/Membro del Consiglio | 12/05/2026 |
ACT Genomics Co. Ltd.
 ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Presidente | 01/01/2022 |
Aurora Tele-Oncology Ltd.
 Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Operates an oncology-specific teleconsultation platform striving to improve cancer care | Fondatore | - |
Chinese Thoracic Oncology Group | Fondatore | - |
Asia Thoracic Oncology Research Group | Fondatore | - |
Formazione di Shu Kam Mok
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
31
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
HUTCHMED (China) Ltd.
 HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
International Association for the Study of Lung Cancer
 International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention. | Commercial Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
Chinese Society of Clinical Oncology | |
Sanomics Ltd.
 Sanomics Ltd. Miscellaneous Commercial ServicesCommercial Services Specializes in blood-based genomics technologies for cancer patients | Commercial Services |
Chinese Thoracic Oncology Group | |
Asia Thoracic Oncology Research Group | |
Aurora Tele-Oncology Ltd.
Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Operates an oncology-specific teleconsultation platform striving to improve cancer care | Health Services |
Lunit Usa, Inc. |
